Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHR-9839 in Advanced Esophageal Squamous Cell Carcinoma
NCT07751341Phase 2Recruiting
- Sponsor
- Suzhou Suncadia Biopharmaceutical
- Start
- Sep 2026
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
A Phase 2 trial of SHR-9839 in Esophageal Squamous Cell Carcinoma (ESCC), sponsored by Suzhou Suncadia Biopharmaceutical. Started Sep 2026; status: recruiting.
02
Drugs
SHR-9839
03
Conditions
Esophageal Squamous Cell Carcinoma (ESCC)
Beyond the preview
Go deeper on NCT07751341.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07751341.